Description
Aprahydro
Composition: Hydroxyurea IP 500mg
Therapeutic Class: Antineoplastic
Aprazer’s Aprahydro: A Global Standard in Oncology Care
Scientific formula backed by WHO certification, Aprahydro is globally prescribed by healthcare professionals.
Aprazer is committed to making essential healthcare accessible to all. It manufactures affordable anticancer medicines that are widely available worldwide and exported to 50+ countries.
Broad Uses of Aprahydro
Aprahydro is widely used in blood, bone marrow, and solid tumor cancers.
- • Chronic Myeloid Leukemia (CML)
- • Melanoma
- • Metastatic Carcinoma of the Ovary and recurrent cases
- • Squamous Cell Carcinoma of the Head and Neck
How does Aprahydro work?
- • Inhibits conversion of RNA to DNA, disrupting DNA synthesis
- • Arrests DNA cycle, leading to cancer cell death
Common Side Effects
- • Bruising
- • Mouth ulcers
- • Skin rashes and dryness
- • Fever
- • Hair loss
Serious Side Effects
These are usually dose-dependent toxicities due to cumulative response.
- • Bone marrow suppression causing significant drop in blood counts
- • Severe skin ulceration and pigmentation at high doses
- • Severe diarrhea, vomiting, dehydration
High Dose Toxicity Risks
- • Renal toxicity
- • Hepatotoxicity
- • Pulmonary toxicity
Contraindications
Not to be used in patients with prior hypersensitivity to the drug or its excipients.
Precautions
To be cautiously used in :
- • Renal insufficient patients
- • Pregnant women
- • Breastfeeding mothers
Warning
It is a prescription drug to be given under medical supervision.
Important Safety Note
Aprahydro is generally well tolerated, but requires regular monitoring for hematological functions, infections, renal functions, and skin changes.
